BIOMAT Database Logo BIOMAT Database Logo

Antibodies to human immunodeficiency virus type 1 in the urine specimens of HIV-1-seropositive individuals. 1989

Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
New York University Medical Center, Department of Microbiology, NY 10016.

Specific antibodies to human immunodeficiency virus type 1 (HIV-1) were detected in 200-fold concentrated urine samples, but none were detected in unconcentrated urine specimens, from 100 randomly selected HIV-1--seropositive individuals by enzyme-linked immunosorbent assay (ELISA) and Western blot techniques using the manufacturer's recommended procedures. Using modified methods for both the ELISA and Western blot tests, antibodies to HIV-1 have also been detected in the unconcentrated urine specimens from the same HIV-1--seropositive individuals. No difference in the frequency of antibodies to HIV-1 were found between unconcentrated and 200-fold concentrated urine samples when tested by the modified methods. HIV-1 core antigen (p24) was not detected in either the concentrated or the unconcentrated HIV-1--seropositive adult urine samples; none of these individuals showed overt clinical or laboratory evidence of renal dysfunction. The titer of the antibodies to HIV-1 found in the urine specimens was found to be parallel with the titer of antibodies to HIV-1 in the corresponding individual's serum. Further elucidation of the pathophysiology and the nature of the specific antibodies to HIV-1 observed in the urine of HIV-1--seropositive individuals is under investigation in our laboratories.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
Detection of human immunodeficiency virus type 1 (HIV-1) in urine cell pellets from HIV-1-seropositive individuals.
May 1992, Journal of clinical microbiology,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals.
December 2008, Retrovirology,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
HIV-1 neutralizing antibodies in urine from seropositive individuals.
January 1990, Journal of acquired immune deficiency syndromes,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study.
July 1991, Archives of neurology,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
November 1991, Proceedings of the National Academy of Sciences of the United States of America,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
[Isolation of human immunodeficiency virus type 1 (HIV-1) from seropositive hemophiliac Japanese].
February 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.
January 1990, Journal of clinical microbiology,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.
January 1990, Disease markers,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.
May 1989, Proceedings of the National Academy of Sciences of the United States of America,
Y Z Cao, and B Hosein, and W Borkowsky, and M Mirabile, and L Baker, and D Baldwin, and B J Poiesz, and A E Friedman-Kien
Human immunodeficiency virus-1 infection in spouses of seropositive individuals.
January 1993, The National medical journal of India,
Copied contents to your clipboard!